First Trust Advisors »

Entrada Therapeutics shares owned by First Trust Advisors

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.3M 74k 17.29
2024-09-30 $1.3M 82k 15.98

More positions owned by First Trust Advisors

Cisco Systems (CSCO)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
International Business Machines (IBM)
Apple (AAPL)
First Tr Exchange-traded Dj Internt Idx (FDN)
First Tr Exchange Traded Finls Alphadex (FXO)
First Tr Nasdaq 100 Tech Ind SHS (QTEC)
First Tr Exchange Traded Consumr Discre (FXD)
Crowdstrike Hldgs Cl A (CRWD)
Palo Alto Networks (PANW)
Alphabet Cap Stk Cl A (GOOGL)
First Tr Exchange Traded Indls Prod Dur (FXR)

View all positions for First Trust Advisors

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
MPM Asset Management
T. Rowe Price Associates
Henderson Group
BlackRock
Vanguard Group
FMR
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
Northern Trust
Goldman Sachs Group

View all funds holding Entrada Therapeutics